Clinical Trial Update: Hydros Joint Therapy and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis (OA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for two Hydros joint therapies assessing pain in knee osteoarthritis; the study sponsored by Carbylan Therapeutics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Hydros Joint Therapy
• Hydros-TA Joint Therapy

Snippet

Sponsor: Carbylan Therapeutics, Inc. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED